Keurig Dr Pepper price target lowered to $37 from $40 at Wedbush

Wedbush lowered the firm’s price target on Keurig Dr Pepper to $37 from $40 and keeps an Outperform rating on the shares. While Keurig Dr Pepper is the only company to have gained share in CSDs every month year-to-date, and while performance is likely to be strong in Q2 headed into the back half of the year, the overwhelming focus on the earnings call is going to center around coffee, which has not shown any signs of improvement, the analyst tells investors in a research note.